Reported figures and Equlion model projections for the next 5 years.
Metric
2025 (actual)
2026
2027
2028
2029
2030
Trend
ROA
-104.81%
-143.71%
-152.26%
-164.36%
-172.7%
-176.69%
Gross Margin
100%
100%
100%
100%
100%
100%
Sector average
16.85%
17.71%
17.71%
17.71%
17.71%
17.71%
Net Margin
-523.75%
-516.44%
-494.87%
-483.85%
-471.87%
-465.77%
Total Assets
SEK 32,533.00K
SEK 32,216.57K
SEK 33,367.49K
SEK 34,863.75K
Amounts in SEK (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.
Want the full financial forecast report for Klaria Pharma Holding AB (publ.)? It covers the balance sheet, income statement and Equlion model projections.
SEK 36,164.85K
SEK 36,912.82K
Sector average
SEK 2,857,190.78K
SEK 2,900,240.60K
SEK 3,045,009.79K
SEK 3,280,286.42K
SEK 3,536,407.14K
SEK 3,762,908.71K
Net Income
-SEK 47,059.00K
-SEK 46,525.90K
-SEK 49,929.78K
-SEK 56,071.58K
-SEK 61,332.89K
-SEK 64,559.31K
Sector average
-SEK 2,851.32K
-SEK 22,027.28K
-SEK 904.69K
-SEK 7,253.84K
-SEK 3,858.45K
-SEK 1,547.00K
Valuation
SEK 163,820.12K
SEK 161,964.33K
SEK 173,813.78K
SEK 195,194.39K
SEK 213,509.87K
SEK 224,741.58K
Sector average
SEK 3,960,502.41K
SEK 5,151,301.60K
SEK 5,189,236.02K
SEK 5,317,343.69K
SEK 5,514,329.75K
SEK 5,636,782.17K
Stock Price
SEK 0.67
SEK 0.66
SEK 0.71
SEK 0.79
SEK 0.87
SEK 0.91
Sector average
SEK 57.22
SEK 48.04
SEK 48.69
SEK 50.45
SEK 52.13
SEK 53.41
Klaria Pharma Holding AB (publ.) (KLAR.ST) Financial Forecast | Equlion